Dora Mbanya
- Mbanya, Dora; Binam, Fidele; Kaptue, Lazare (2001-01-01): Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation: [1]
- Mbanya, Dora; Ateudjieu, Jerome; Tagny, Claude Tayou; Moudourou, Sylvie; Lobe, Marcel Monny; Kaptue, Lazare (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon[2]
- Anye, Angwafor; Tasha, Ngwanui; Njamnshi, Alfred; Mbanya, Dora: Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon[3]
- Mbanya, Dora: Barriers and enablers to introducing comprehensive patient blood management in the hospital[4]
- Tagny, Claude Tayou; Mbanya, Dora; Murphy, Edward L.; Lefrère, Jean-Jacques; Laperche, Syria: Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test[5]
- Mbanya, Dora Ngum; Zebaze, Roger; Minkoulou, Etienne-Magloire; Binam, Fidele; Koulla, Sinata; Obounou, Akong: Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective[6]
- Mbanya, Dora; Assah, Felix; Ndembi, Nicaise; Kaptue, Lazare: Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? [7]
- Mbanya, Dora; Binam, Fidele; Kaptue, Lazare (2001-01-01): Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation: [8]
- Mbanya, Dora; Ateudjieu, Jerome; Tagny, Claude Tayou; Moudourou, Sylvie; Lobe, Marcel Monny; Kaptue, Lazare (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon[9]
- Anye, Angwafor; Tasha, Ngwanui; Njamnshi, Alfred; Mbanya, Dora: Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon[10]
- Mbanya, Dora: Barriers and enablers to introducing comprehensive patient blood management in the hospital[11]
- Tagny, Claude Tayou; Mbanya, Dora; Murphy, Edward L.; Lefrère, Jean-Jacques; Laperche, Syria: Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test[12]
- Mbanya, Dora Ngum; Zebaze, Roger; Minkoulou, Etienne-Magloire; Binam, Fidele; Koulla, Sinata; Obounou, Akong: Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective[13]
- Mbanya, Dora; Assah, Felix; Ndembi, Nicaise; Kaptue, Lazare: Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? [14]
Dora Ngum Shu Mbanya (amụrụ n'ubochi 13 n'ọnwa Disemba 1956) bụ onye mba Cameroon Prọfesọ nke Haematology na Mahadum Yaoundé I (UYI) na onye isi nke alaka mba Kameroon nke mba Afrika Ogbako nke umunwanyi ọrịa Aids n' Afrika.[15][16][17][18][19]
Dora Ngum Shu Mbanya
| |
---|---|
A mụrụ ya | Dora Ngum Shu 13 Disemba 1956 (afọ 67) Ebe Ugwu Ọdịda Anyanwụ, Cameroon, Ebe ỌdịdaAnyanwụ AfricaEbe Ọdịda Anyanwụ Afrịka
|
Ụmụ amaala | Cameroon |
Alma mater | Page Àtụ:Plainlist/styles.css has no content.
|
A maara ya maka | nchọpụta nke subgenotype ọhụrụ nke nje hepatitis b (a3), hepatitis delta na ụdị c. |
Nwunye | Jean Claude Mbanya |
Ọrụ sayensị | |
Ubi | Ọgwụ mmịnye ọbara na ojiji ọgwụgwọ nke ọbara. |
Ụlọ ọrụ | Page Àtụ:Plainlist/styles.css has no content.
|
Akụkọ ndụ
dezieA mụrụ Dora Mbanya n'ubochị 13, n'ọnwa Disemba n'afọ 1956 na mpaghara Ọdịda Anyanwuụ nke Kameroon. Ọ bụ dọkịta ma bụrụ ọkachamara na haematology.[20] O nwetara akara ugo mmụta ọgwụ na General Medicine site na Kameroon wee nweta PhD ya na Medicine / Haematology site na Newcastle upon Tyne, England. O nwere Dîplome Universitaire na Transfusion Medicine site na Mahadum nke Abidjan, n'obodo Côte d'Ivoire. Ọ bụkwa onye isi njikwa nke National Blood Transfusion Service na kameroon na onye isi oche nke Nzuko Afrika maka mminye Ọbara .Ọ lụrụ prọfesọ ọzọ nke Medicine na Endocrinology, Jean Claude Mbanya.[15][21][19]
Mmasị nyocha
dezieDora Mbaya lekwasịrị anya na ọgwụ mmịnye ọbara, ojiji ọgwụgwọ nke ọbara; ọrịa mmịnye-ebute (TTIs) dị ka ịba ọcha n'anya B, C, Syphilis, Nje HIV.[15]
Enyemaka sayensị
dezieDora na ndị otu ya nwere ike ịchọpụta ụdị ọhụrụ nke nje hepatitis b (a3), hepatitis delta na ụdị c. ha chọpụtakwara nnyefe dị larịị nke otu n, hiv-1 na hiv-2 intergroup recombinant strain. N'ọrụ ha, ha gosipụtara na ọgwụ mgbochi bụ isi na ndị n'arịa ọrịa HIV na-amaghị, ma gosipụta n'ụzọ sara mbara ọdịiche dị iche iche nke HIV-1 na mba Kameroon. Enyemaka ndị a emeela ka e mepụta nyocha nyocha maka ịchọpụta ụdị ọrịa HIV dị iche iche na ụdị ahụike.[15]
Akwụkwọ ndị a họọrọ
dezie- Mbanya, Dora; Binam, Fidele; Kaptue, Lazare (2001-01-01): Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation: [22]
- Mbanya, Dora; Ateudjieu, Jerome; Tagny, Claude Tayou; Moudourou, Sylvie; Lobe, Marcel Monny; Kaptue, Lazare (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon[23]
- Anye, Angwafor; Tasha, Ngwanui; Njamnshi, Alfred; Mbanya, Dora: Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon[24]
- Mbanya, Dora: Barriers and enablers to introducing comprehensive patient blood management in the hospital[25]
- Tagny, Claude Tayou; Mbanya, Dora; Murphy, Edward L.; Lefrère, Jean-Jacques; Laperche, Syria: Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test[26]
- Mbanya, Dora Ngum; Zebaze, Roger; Minkoulou, Etienne-Magloire; Binam, Fidele; Koulla, Sinata; Obounou, Akong: Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective[27]
- Mbanya, Dora; Assah, Felix; Ndembi, Nicaise; Kaptue, Lazare: Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts? [28]
- ↑ Mbanya (2001-01-01). "Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation" (in en). International Journal of Infectious Diseases 5 (2): 70–73. DOI:10.1016/S1201-9712(01)90028-1. ISSN 1201-9712. PMID 11468100.
- ↑ Mbanya (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon" (in en). International Journal of Environmental Research and Public Health 7 (5): 2085–2100. DOI:10.3390/ijerph7052085. PMID 20623013.
- ↑ Anye (2021-10-01). "Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon" (in en). Journal of the Neurological Sciences 429: 118934. DOI:10.1016/j.jns.2021.118934. ISSN 0022-510X.
- ↑ Mbanya (2012-05-01). "Barriers and enablers to introducing comprehensive patient blood management in the hospital" (in en). Biologicals 40 (3): 205–208. DOI:10.1016/j.biologicals.2012.01.003. ISSN 1045-1056. PMID 22316645.
- ↑ Tagny (2014-04-01). "Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test" (in en). Journal of Virological Methods 199: 119–123. DOI:10.1016/j.jviromet.2014.01.002. ISSN 0166-0934. PMID 24487098.
- ↑ Mbanya (2002-06-01). "Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective" (in en). International Journal of Infectious Diseases 6 (2): 134–138. DOI:10.1016/S1201-9712(02)90075-5. ISSN 1201-9712. PMID 12121602.
- ↑ Mbanya (2007-03-01). "Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?" (in en). International Journal of Infectious Diseases 11 (2): 157–160. DOI:10.1016/j.ijid.2006.02.008. ISSN 1201-9712. PMID 16762583.
- ↑ Mbanya (2001-01-01). "Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation" (in en). International Journal of Infectious Diseases 5 (2): 70–73. DOI:10.1016/S1201-9712(01)90028-1. ISSN 1201-9712. PMID 11468100.
- ↑ Mbanya (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon" (in en). International Journal of Environmental Research and Public Health 7 (5): 2085–2100. DOI:10.3390/ijerph7052085. PMID 20623013.
- ↑ Anye (2021-10-01). "Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon" (in en). Journal of the Neurological Sciences 429: 118934. DOI:10.1016/j.jns.2021.118934. ISSN 0022-510X.
- ↑ Mbanya (2012-05-01). "Barriers and enablers to introducing comprehensive patient blood management in the hospital" (in en). Biologicals 40 (3): 205–208. DOI:10.1016/j.biologicals.2012.01.003. ISSN 1045-1056. PMID 22316645.
- ↑ Tagny (2014-04-01). "Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test" (in en). Journal of Virological Methods 199: 119–123. DOI:10.1016/j.jviromet.2014.01.002. ISSN 0166-0934. PMID 24487098.
- ↑ Mbanya (2002-06-01). "Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective" (in en). International Journal of Infectious Diseases 6 (2): 134–138. DOI:10.1016/S1201-9712(02)90075-5. ISSN 1201-9712. PMID 12121602.
- ↑ Mbanya (2007-03-01). "Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?" (in en). International Journal of Infectious Diseases 11 (2): 157–160. DOI:10.1016/j.ijid.2006.02.008. ISSN 1201-9712. PMID 16762583.
- ↑ 15.0 15.1 15.2 15.3 Dora Mbanya | The AAS. www.aasciences.africa. Archived from the original on 2022-12-31. Retrieved on 2023-02-06. Kpọpụta njehie: Invalid
<ref>
tag; name ":0" defined multiple times with different content - ↑ Dora Mbanya – AfSBT (en-US). Retrieved on 2023-02-06.
- ↑ Press. Professor DN Mbanya | Dove Press editor profile. www.dovepress.com. Retrieved on 2023-02-06.
- ↑ ISBT. The 4th AfSBT Educational Webinar. www.isbtweb.org. Retrieved on 2023-02-06.
- ↑ 19.0 19.1 Professor Dora Mbanya : Haematologist For Community's Welfare (en). www.cameroon-tribune.cm. Retrieved on 2023-02-06. Kpọpụta njehie: Invalid
<ref>
tag; name ":1" defined multiple times with different content - ↑ Professor Dora Mbanya : Haematologist For Community's Welfare (en). www.cameroon-tribune.cm. Retrieved on 2023-02-07.
- ↑ echosante (2021-05-04). Blood Transfusion – Prof. Dora Mbanya Urges Cameroonians To Save Lives Through Blood Donation (fr-FR). Echos Santé. Retrieved on 2023-02-07.
- ↑ Mbanya (2001-01-01). "Transfusion outcome in a resource-limited setting of Cameroon: A five-year evaluation" (in en). International Journal of Infectious Diseases 5 (2): 70–73. DOI:10.1016/S1201-9712(01)90028-1. ISSN 1201-9712. PMID 11468100.
- ↑ Mbanya (2010). "Risk Factors for Transmission of HIV in a Hospital Environment of Yaoundé, Cameroon" (in en). International Journal of Environmental Research and Public Health 7 (5): 2085–2100. DOI:10.3390/ijerph7052085. PMID 20623013.
- ↑ Anye (2021-10-01). "Chronic pain amongst HIV-infected adults followed-up at the Bamenda Regional Hospital, Cameroon" (in en). Journal of the Neurological Sciences 429: 118934. DOI:10.1016/j.jns.2021.118934. ISSN 0022-510X.
- ↑ Mbanya (2012-05-01). "Barriers and enablers to introducing comprehensive patient blood management in the hospital" (in en). Biologicals 40 (3): 205–208. DOI:10.1016/j.biologicals.2012.01.003. ISSN 1045-1056. PMID 22316645.
- ↑ Tagny (2014-04-01). "Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test" (in en). Journal of Virological Methods 199: 119–123. DOI:10.1016/j.jviromet.2014.01.002. ISSN 0166-0934. PMID 24487098.
- ↑ Mbanya (2002-06-01). "Clinical and epidemiologic trends in HIV/AIDS patients in a hospital setting of Yaounde, Cameroon: a 6-year perspective" (in en). International Journal of Infectious Diseases 6 (2): 134–138. DOI:10.1016/S1201-9712(02)90075-5. ISSN 1201-9712. PMID 12121602.
- ↑ Mbanya (2007-03-01). "Monitoring antiretroviral therapy in HIV/AIDS patients in resource-limited settings: CD4 counts or total lymphocyte counts?" (in en). International Journal of Infectious Diseases 11 (2): 157–160. DOI:10.1016/j.ijid.2006.02.008. ISSN 1201-9712. PMID 16762583.